BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chang JC. Acute Respiratory Distress Syndrome as an Organ Phenotype of Vascular Microthrombotic Disease: Based on Hemostatic Theory and Endothelial Molecular Pathogenesis. Clin Appl Thromb Hemost 2019;25:1076029619887437. [PMID: 31775524 DOI: 10.1177/1076029619887437] [Cited by in Crossref: 47] [Cited by in F6Publishing: 43] [Article Influence: 23.5] [Reference Citation Analysis]
Number Citing Articles
1 Segrelles-Calvo G, de S Araújo GR, Frases S. Systemic mycoses: a potential alert for complications in COVID-19 patients. Future Microbiol 2020;15:1405-13. [PMID: 33085538 DOI: 10.2217/fmb-2020-0156] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
2 Hawley HB, Chang JC. Complement-Induced Endotheliopathy-Associated Vascular Microthrombosis in Coronavirus Disease 2019. J Infect Dis 2021;223:2198-9. [PMID: 33715011 DOI: 10.1093/infdis/jiab136] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Joly BS, Siguret V, Veyradier A. Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19. Intensive Care Med 2020;46:1603-6. [PMID: 32415314 DOI: 10.1007/s00134-020-06088-1] [Cited by in Crossref: 64] [Cited by in F6Publishing: 52] [Article Influence: 32.0] [Reference Citation Analysis]
4 Keith P, Day M, Choe C, Perkins L, Moyer L, Hays E, French M, Hewitt K, Gravel G, Guffey A, Scott LK. The successful use of therapeutic plasma exchange for severe COVID-19 acute respiratory distress syndrome with multiple organ failure. SAGE Open Med Case Rep 2020;8:2050313X20933473. [PMID: 32595974 DOI: 10.1177/2050313X20933473] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
5 Oliveira E, Parikh A, Lopez-Ruiz A, Carrilo M, Goldberg J, Cearras M, Fernainy K, Andersen S, Mercado L, Guan J, Zafar H, Louzon P, Carr A, Baloch N, Pratley R, Silverstry S, Hsu V, Sniffen J, Herrera V, Finkler N. ICU outcomes and survival in patients with severe COVID-19 in the largest health care system in central Florida. PLoS One 2021;16:e0249038. [PMID: 33765049 DOI: 10.1371/journal.pone.0249038] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
6 Cui N, Jiang C, Chen H, Zhang L, Feng X. Prevalence, risk, and outcome of deep vein thrombosis in acute respiratory distress syndrome. Thromb J 2021;19:71. [PMID: 34645471 DOI: 10.1186/s12959-021-00325-3] [Reference Citation Analysis]
7 Chang JC. Disseminated intravascular coagulation: new identity as endotheliopathy-associated vascular microthrombotic disease based on in vivo hemostasis and endothelial molecular pathogenesis. Thromb J 2020;18:25. [PMID: 33061857 DOI: 10.1186/s12959-020-00231-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
8 Vacchi C, Meschiari M, Milic J, Marietta M, Tonelli R, Alfano G, Volpi S, Faltoni M, Franceschi G, Ciusa G, Bacca E, Tutone M, Raimondi A, Menozzi M, Franceschini E, Cuomo G, Orlando G, Santoro A, Di Gaetano M, Puzzolante C, Carli F, Bedini A, Cossarizza A, Castaniere I, Ligabue G, De Ruvo N, Manco G, Rolando G, Gelmini R, Maiorana A, Girardis M, Mascia MT, Mussini C, Salvarani C, Guaraldi G. COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion. Rheumatology (Oxford) 2020;59:e147-50. [PMID: 32968761 DOI: 10.1093/rheumatology/keaa581] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
9 Eketunde AO, Mellacheruvu SP, Oreoluwa P. A Review of Postmortem Findings in Patients With COVID-19. Cureus 2020;12:e9438. [PMID: 32864262 DOI: 10.7759/cureus.9438] [Cited by in Crossref: 4] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
10 Chang JC. Stroke Classification: Critical Role of Unusually Large von Willebrand Factor Multimers and Tissue Factor on Clinical Phenotypes Based on Novel "Two-Path Unifying Theory" of Hemostasis. Clin Appl Thromb Hemost 2020;26:1076029620913634. [PMID: 32584600 DOI: 10.1177/1076029620913634] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Vorobyev PA, Momot AP, Krasnova LS, Vorobiev AP, Talipov AK. [Pathogenesis, diagnosis, prevention and treatment of disseminated intravascular coagulation syndrome in COVID-19 infection]. Ter Arkh 2020;92:51-6. [PMID: 33720604 DOI: 10.26442/00403660.2020.11.000887] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
12 Rolla R, Puricelli C, Bertoni A, Boggio E, Gigliotti CL, Chiocchetti A, Cappellano G, Dianzani U. Platelets: 'multiple choice' effectors in the immune response and their implication in COVID-19 thromboinflammatory process. Int J Lab Hematol 2021. [PMID: 33749995 DOI: 10.1111/ijlh.13516] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
13 Balagholi S, Dabbaghi R, Eshghi P, Mousavi SA, Heshmati F, Mohammadi S. Potential of therapeutic plasmapheresis in treatment of COVID-19 patients: Immunopathogenesis and coagulopathy. Transfus Apher Sci 2020;59:102993. [PMID: 33162341 DOI: 10.1016/j.transci.2020.102993] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
14 Pan P, Li Y, Xiao Y, Han B, Su L, Su M, Li Y, Zhang S, Jiang D, Chen X, Zhou F, Ma L, Bao P, Xie L. Prognostic Assessment of COVID-19 in the Intensive Care Unit by Machine Learning Methods: Model Development and Validation. J Med Internet Res 2020;22:e23128. [PMID: 33035175 DOI: 10.2196/23128] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
15 Patidar GK, Land KJ, Vrielink H, Rahimi-Levene N, Dann EJ, Al-Humaidan H, Spitalnik SL, Dhiman Y, So-Osman C, Hindawi SI. Understanding the role of therapeutic plasma exchange in COVID-19: preliminary guidance and practices. Vox Sang 2021;116:798-807. [PMID: 33730761 DOI: 10.1111/vox.13067] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
16 Varghese PM, Tsolaki AG, Yasmin H, Shastri A, Ferluga J, Vatish M, Madan T, Kishore U. Host-pathogen interaction in COVID-19: Pathogenesis, potential therapeutics and vaccination strategies. Immunobiology 2020;225:152008. [PMID: 33130519 DOI: 10.1016/j.imbio.2020.152008] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 7.0] [Reference Citation Analysis]
17 Marongiu F, Grandone E, Barcellona D. Pulmonary thrombosis in 2019-nCoV pneumonia? J Thromb Haemost. 2020;18:1511-1513. [PMID: 32293083 DOI: 10.1111/jth.14818] [Cited by in Crossref: 47] [Cited by in F6Publishing: 42] [Article Influence: 23.5] [Reference Citation Analysis]
18 Park JF, Banerjee S, Umar S. In the eye of the storm: the right ventricle in COVID-19. Pulm Circ 2020;10:2045894020936660. [PMID: 32655856 DOI: 10.1177/2045894020936660] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 8.0] [Reference Citation Analysis]
19 Chang JC. COVID-19 Sepsis: Pathogenesis and Endothelial Molecular Mechanisms Based on "Two-Path Unifying Theory" of Hemostasis and Endotheliopathy-Associated Vascular Microthrombotic Disease, and Proposed Therapeutic Approach with Antimicrothrombotic Therapy. Vasc Health Risk Manag 2021;17:273-98. [PMID: 34103921 DOI: 10.2147/VHRM.S299357] [Reference Citation Analysis]
20 Frydman GH, Streiff MB, Connors JM, Piazza G. The Potential Role of Coagulation Factor Xa in the Pathophysiology of COVID-19: A Role for Anticoagulants as Multimodal Therapeutic Agents. TH Open 2020;4:e288-99. [PMID: 33043235 DOI: 10.1055/s-0040-1718415] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
21 Chen CM, Lu HC, Tung YT, Chen W. Antiplatelet Therapy for Acute Respiratory Distress Syndrome. Biomedicines 2020;8:E230. [PMID: 32708068 DOI: 10.3390/biomedicines8070230] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
22 Xu G, Wan H, Yi L, Chen W, Luo Y, Huang Y, Liu X. Berberine administrated with different routes attenuates inhaled LPS-induced acute respiratory distress syndrome through TLR4/NF-κB and JAK2/STAT3 inhibition. Eur J Pharmacol 2021;908:174349. [PMID: 34284014 DOI: 10.1016/j.ejphar.2021.174349] [Reference Citation Analysis]
23 Stiel L, Rabouel Y, Debliquis A, Pointurier V, Mootien J, Kuteifan K. NEUT-SFL in Patients with COVID-ARDS: A Novel Biomarker for Thrombotic Events? Dis Markers 2021;2021:4361844. [PMID: 34840629 DOI: 10.1155/2021/4361844] [Reference Citation Analysis]
24 Colling ME, Kanthi Y. COVID-19-associated coagulopathy: An exploration of mechanisms. Vasc Med. 2020;25:471-478. [PMID: 32558620 DOI: 10.1177/1358863x20932640] [Cited by in Crossref: 73] [Cited by in F6Publishing: 47] [Article Influence: 36.5] [Reference Citation Analysis]
25 Iba T, Connors JM, Levy JH. The coagulopathy, endotheliopathy, and vasculitis of COVID-19. Inflamm Res 2020;69:1181-9. [PMID: 32918567 DOI: 10.1007/s00011-020-01401-6] [Cited by in Crossref: 71] [Cited by in F6Publishing: 88] [Article Influence: 35.5] [Reference Citation Analysis]
26 Fröhlich E. Acute Respiratory Distress Syndrome: Focus on Viral Origin and Role of Pulmonary Lymphatics. Biomedicines 2021;9:1732. [PMID: 34829961 DOI: 10.3390/biomedicines9111732] [Reference Citation Analysis]
27 Cruz Rodriguez JB, Lange RA, Mukherjee D. Gamut of cardiac manifestations and complications of COVID-19: a contemporary review. J Investig Med 2020;68:1334-40. [PMID: 33077488 DOI: 10.1136/jim-2020-001592] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Watanabe-Kusunoki K, Nakazawa D, Ishizu A, Atsumi T. Thrombomodulin as a Physiological Modulator of Intravascular Injury. Front Immunol 2020;11:575890. [PMID: 33042158 DOI: 10.3389/fimmu.2020.575890] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
29 Remmelink M, De Mendonça R, D'Haene N, De Clercq S, Verocq C, Lebrun L, Lavis P, Racu ML, Trépant AL, Maris C, Rorive S, Goffard JC, De Witte O, Peluso L, Vincent JL, Decaestecker C, Taccone FS, Salmon I. Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients. Crit Care 2020;24:495. [PMID: 32787909 DOI: 10.1186/s13054-020-03218-5] [Cited by in Crossref: 103] [Cited by in F6Publishing: 102] [Article Influence: 51.5] [Reference Citation Analysis]
30 Krzych ŁJ, Putowski Z, Czok M, Hofman M. What Is the Role of Therapeutic Plasma Exchange as an Adjunctive Treatment in Severe COVID-19: A Systematic Review. Viruses 2021;13:1484. [PMID: 34452349 DOI: 10.3390/v13081484] [Reference Citation Analysis]
31 Brogna B, Brogna C, Martino A, Minichiello S, Romeo DM, Romano P, Bignardi E, Mazza EM, Musto L. SARS-CoV-2 Infection with Different Radiological Insights. Diagnostics (Basel) 2020;10:E283. [PMID: 32392859 DOI: 10.3390/diagnostics10050283] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
32 Marietta M, Coluccio V, Luppi M. COVID-19, coagulopathy and venous thromboembolism: more questions than answers. Intern Emerg Med 2020;15:1375-87. [PMID: 32653981 DOI: 10.1007/s11739-020-02432-x] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 16.5] [Reference Citation Analysis]
33 Di Micco P, Russo V, Carannante N, Imparato M, Rodolfi S, Cardillo G, Lodigiani C. Clotting Factors in COVID-19: Epidemiological Association and Prognostic Values in Different Clinical Presentations in an Italian Cohort. J Clin Med 2020;9:E1371. [PMID: 32392741 DOI: 10.3390/jcm9051371] [Cited by in Crossref: 38] [Cited by in F6Publishing: 35] [Article Influence: 19.0] [Reference Citation Analysis]
34 Caramaschi S, Kapp ME, Miller SE, Eisenberg R, Johnson J, Epperly G, Maiorana A, Silvestri G, Giannico GA. Histopathological findings and clinicopathologic correlation in COVID-19: a systematic review. Mod Pathol 2021;34:1614-33. [PMID: 34031537 DOI: 10.1038/s41379-021-00814-w] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
35 Bikdeli B, Madhavan MV, Gupta A, Jimenez D, Burton JR, Der Nigoghossian C, Chuich T, Nouri SN, Dreyfus I, Driggin E, Sethi S, Sehgal K, Chatterjee S, Ageno W, Madjid M, Guo Y, Tang LV, Hu Y, Bertoletti L, Giri J, Cushman M, Quéré I, Dimakakos EP, Gibson CM, Lippi G, Favaloro EJ, Fareed J, Tafur AJ, Francese DP, Batra J, Falanga A, Clerkin KJ, Uriel N, Kirtane A, McLintock C, Hunt BJ, Spyropoulos AC, Barnes GD, Eikelboom JW, Weinberg I, Schulman S, Carrier M, Piazza G, Beckman JA, Leon MB, Stone GW, Rosenkranz S, Goldhaber SZ, Parikh SA, Monreal M, Krumholz HM, Konstantinides SV, Weitz JI, Lip GYH; Global COVID-19 Thrombosis Collaborative Group. Pharmacological Agents Targeting Thromboinflammation in COVID-19: Review and Implications for Future Research. Thromb Haemost 2020;120:1004-24. [PMID: 32473596 DOI: 10.1055/s-0040-1713152] [Cited by in Crossref: 99] [Cited by in F6Publishing: 95] [Article Influence: 49.5] [Reference Citation Analysis]
36 Bos LDJ, Artigas A, Constantin JM, Hagens LA, Heijnen N, Laffey JG, Meyer N, Papazian L, Pisani L, Schultz MJ, Shankar-Hari M, Smit MR, Summers C, Ware LB, Scala R, Calfee CS. Precision medicine in acute respiratory distress syndrome: workshop report and recommendations for future research. Eur Respir Rev 2021;30:200317. [PMID: 33536264 DOI: 10.1183/16000617.0317-2020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
37 Cui N, Mi S, Jiang C, Sun W, Mao W, Zhang L, Feng X. Deep vein thrombosis in acute respiratory distress syndrome caused by bacterial pneumonia. BMC Pulm Med 2021;21:264. [PMID: 34391407 DOI: 10.1186/s12890-021-01632-1] [Reference Citation Analysis]
38 Valga F, Vega-Díaz N, Macia M, Monzón T, Rodriguez-Perez JC. Targeting complement in severe coronavirus disease 2019 to address microthrombosis. Clin Kidney J 2020;13:477-9. [PMID: 32695331 DOI: 10.1093/ckj/sfaa095] [Cited by in Crossref: 11] [Cited by in F6Publishing: 7] [Article Influence: 5.5] [Reference Citation Analysis]
39 Yusuff H, Zochios V, Brodie D. Thrombosis and Coagulopathy in COVID-19 Patients Requiring Extracorporeal Membrane Oxygenation. ASAIO J 2020;66:844-6. [PMID: 32740341 DOI: 10.1097/MAT.0000000000001208] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
40 Zhang Q, Hu WT, Yin F, Qian H, Wang Y, Li BR, Qian J, Tang YJ, Ning BT. The Clinical Characteristics of ARDS in Children With Hematological Neoplasms. Front Pediatr 2021;9:696594. [PMID: 34307258 DOI: 10.3389/fped.2021.696594] [Reference Citation Analysis]
41 Ortega-Paz L, Capodanno D, Montalescot G, Angiolillo DJ. Coronavirus Disease 2019-Associated Thrombosis and Coagulopathy: Review of the Pathophysiological Characteristics and Implications for Antithrombotic Management. J Am Heart Assoc 2021;10:e019650. [PMID: 33228447 DOI: 10.1161/JAHA.120.019650] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 11.0] [Reference Citation Analysis]
42 Morales-Quinteros L, Neto AS, Artigas A, Blanch L, Botta M, Kaufman DA, Schultz MJ, Tsonas AM, Paulus F, Bos LD; PRoVENT-COVID Study Group. Dead space estimates may not be independently associated with 28-day mortality in COVID-19 ARDS. Crit Care 2021;25:171. [PMID: 34001222 DOI: 10.1186/s13054-021-03570-0] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
43 Iba T, Levy JH, Connors JM, Warkentin TE, Thachil J, Levi M. Managing thrombosis and cardiovascular complications of COVID-19: answering the questions in COVID-19-associated coagulopathy. Expert Rev Respir Med 2021;15:1003-11. [PMID: 33667146 DOI: 10.1080/17476348.2021.1899815] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
44 Tabibi S, Tabibi T, Conic RRZ, Banisaeed N, Streiff MB. Therapeutic Plasma Exchange: A potential Management Strategy for Critically Ill COVID-19 Patients. J Intensive Care Med 2020;35:827-35. [PMID: 32666875 DOI: 10.1177/0885066620940259] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 8.0] [Reference Citation Analysis]
45 Huber-Lang MS, Ignatius A, Köhl J, Mannes M, Braun CK. Complement in trauma-Traumatised complement? Br J Pharmacol 2021;178:2863-79. [PMID: 32880897 DOI: 10.1111/bph.15245] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
46 Carvallo FR, Stevenson VB. Interstitial pneumonia and diffuse alveolar damage in domestic animals. Vet Pathol. [DOI: 10.1177/03009858221082228] [Reference Citation Analysis]
47 Luo CY, Li Y, Li X, Liang X, Wang Q, Ma YH, Xiong CH, Zeng YP, Sun W, Wang X. Alleviation of Lipopolysaccharide-Induced Acute Respiratory Distress Syndrome in Rats by Yiqi Huayu Jiedu Decoction: A Tandem Mass Tag-Based Proteomics Study. Front Pharmacol 2020;11:1215. [PMID: 32982719 DOI: 10.3389/fphar.2020.01215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
48 Delrue M, Siguret V, Neuwirth M, Joly B, Beranger N, Sène D, Chousterman BG, Voicu S, Bonnin P, Mégarbane B, Stépanian A. von Willebrand factor/ADAMTS13 axis and venous thromboembolism in moderate-to-severe COVID-19 patients. Br J Haematol 2021;192:1097-100. [PMID: 33368196 DOI: 10.1111/bjh.17216] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]